Abstract
Summary
The global Degradable Drug Delivery Coating market size is projected to grow from US$ 203.5 million in 2022 to US$ 387.7 million in 2029; it is expected to grow at a CAGR of 9.6% from 2023 to 2029.
United States market for Degradable Drug Delivery Coating is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Degradable Drug Delivery Coating is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Degradable Drug Delivery Coating is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Degradable Drug Delivery Coating players cover Surmodics, Hydromer, DSM Biomedical, Harland Medical Systems, Biocoat, Coatings2Go, AST Products, Surface Solutions Group and ISurTec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
A degradable drug delivery coating is a type of coating that is applied to medical devices, such as stents or implants, to deliver drugs over time. The coating is designed to gradually degrade or dissolve, releasing the drug into the surrounding tissue or bloodstream. The use of degradable drug delivery coatings is an important advancement in medical technology, as it allows for targeted drug delivery to specific areas of the body. The coating can be customized to release the drug at a specific rate, allowing for more precise and effective treatment.
LPI (LP Information)' newest research report, the “Degradable Drug Delivery Coating Industry Forecast” looks at past sales and reviews total world Degradable Drug Delivery Coating sales in 2022, providing a comprehensive analysis by region and market sector of projected Degradable Drug Delivery Coating sales for 2023 through 2029. With Degradable Drug Delivery Coating sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Degradable Drug Delivery Coating industry.
This Insight Report provides a comprehensive analysis of the global Degradable Drug Delivery Coating landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Degradable Drug Delivery Coating portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Degradable Drug Delivery Coating market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Degradable Drug Delivery Coating and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Degradable Drug Delivery Coating.
This report presents a comprehensive overview, market shares, and growth opportunities of Degradable Drug Delivery Coating market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Polymeric Coating
Hydrogel Coating
Lipid-based Coating
Protein-based Coating
Segmentation by application
Drug-eluting Stents
Implants
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Surmodics
Hydromer
DSM Biomedical
Harland Medical Systems
Biocoat
Coatings2Go
AST Products
Surface Solutions Group
ISurTec
AdvanSource Biomaterials
Teleflex
Argon Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Degradable Drug Delivery Coating market?
What factors are driving Degradable Drug Delivery Coating market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Degradable Drug Delivery Coating market opportunities vary by end market size?
How does Degradable Drug Delivery Coating break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
United States market for Degradable Drug Delivery Coating is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Degradable Drug Delivery Coating is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Degradable Drug Delivery Coating is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Degradable Drug Delivery Coating players cover Surmodics, Hydromer, DSM Biomedical, Harland Medical Systems, Biocoat, Coatings2Go, AST Products, Surface Solutions Group and ISurTec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
A degradable drug delivery coating is a type of coating that is applied to medical devices, such as stents or implants, to deliver drugs over time. The coating is designed to gradually degrade or dissolve, releasing the drug into the surrounding tissue or bloodstream. The use of degradable drug delivery coatings is an important advancement in medical technology, as it allows for targeted drug delivery to specific areas of the body. The coating can be customized to release the drug at a specific rate, allowing for more precise and effective treatment.
LPI (LP Information)' newest research report, the “Degradable Drug Delivery Coating Industry Forecast” looks at past sales and reviews total world Degradable Drug Delivery Coating sales in 2022, providing a comprehensive analysis by region and market sector of projected Degradable Drug Delivery Coating sales for 2023 through 2029. With Degradable Drug Delivery Coating sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Degradable Drug Delivery Coating industry.
This Insight Report provides a comprehensive analysis of the global Degradable Drug Delivery Coating landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Degradable Drug Delivery Coating portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Degradable Drug Delivery Coating market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Degradable Drug Delivery Coating and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Degradable Drug Delivery Coating.
This report presents a comprehensive overview, market shares, and growth opportunities of Degradable Drug Delivery Coating market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Polymeric Coating
Hydrogel Coating
Lipid-based Coating
Protein-based Coating
Segmentation by application
Drug-eluting Stents
Implants
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Surmodics
Hydromer
DSM Biomedical
Harland Medical Systems
Biocoat
Coatings2Go
AST Products
Surface Solutions Group
ISurTec
AdvanSource Biomaterials
Teleflex
Argon Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Degradable Drug Delivery Coating market?
What factors are driving Degradable Drug Delivery Coating market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Degradable Drug Delivery Coating market opportunities vary by end market size?
How does Degradable Drug Delivery Coating break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Degradable Drug Delivery Coating Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Degradable Drug Delivery Coating by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Degradable Drug Delivery Coating by Country/Region, 2018, 2022 & 2029
2.2 Degradable Drug Delivery Coating Segment by Type
2.2.1 Polymeric Coating
2.2.2 Hydrogel Coating
2.2.3 Lipid-based Coating
2.2.4 Protein-based Coating
2.3 Degradable Drug Delivery Coating Sales by Type
2.3.1 Global Degradable Drug Delivery Coating Sales Market Share by Type (2018-2023)
2.3.2 Global Degradable Drug Delivery Coating Revenue and Market Share by Type (2018-2023)
2.3.3 Global Degradable Drug Delivery Coating Sale Price by Type (2018-2023)
2.4 Degradable Drug Delivery Coating Segment by Application
2.4.1 Drug-eluting Stents
2.4.2 Implants
2.4.3 Others
2.5 Degradable Drug Delivery Coating Sales by Application
2.5.1 Global Degradable Drug Delivery Coating Sale Market Share by Application (2018-2023)
2.5.2 Global Degradable Drug Delivery Coating Revenue and Market Share by Application (2018-2023)
2.5.3 Global Degradable Drug Delivery Coating Sale Price by Application (2018-2023)
3 Global Degradable Drug Delivery Coating by Company
3.1 Global Degradable Drug Delivery Coating Breakdown Data by Company
3.1.1 Global Degradable Drug Delivery Coating Annual Sales by Company (2018-2023)
3.1.2 Global Degradable Drug Delivery Coating Sales Market Share by Company (2018-2023)
3.2 Global Degradable Drug Delivery Coating Annual Revenue by Company (2018-2023)
3.2.1 Global Degradable Drug Delivery Coating Revenue by Company (2018-2023)
3.2.2 Global Degradable Drug Delivery Coating Revenue Market Share by Company (2018-2023)
3.3 Global Degradable Drug Delivery Coating Sale Price by Company
3.4 Key Manufacturers Degradable Drug Delivery Coating Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Degradable Drug Delivery Coating Product Location Distribution
3.4.2 Players Degradable Drug Delivery Coating Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Degradable Drug Delivery Coating by Geographic Region
4.1 World Historic Degradable Drug Delivery Coating Market Size by Geographic Region (2018-2023)
4.1.1 Global Degradable Drug Delivery Coating Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Degradable Drug Delivery Coating Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Degradable Drug Delivery Coating Market Size by Country/Region (2018-2023)
4.2.1 Global Degradable Drug Delivery Coating Annual Sales by Country/Region (2018-2023)
4.2.2 Global Degradable Drug Delivery Coating Annual Revenue by Country/Region (2018-2023)
4.3 Americas Degradable Drug Delivery Coating Sales Growth
4.4 APAC Degradable Drug Delivery Coating Sales Growth
4.5 Europe Degradable Drug Delivery Coating Sales Growth
4.6 Middle East & Africa Degradable Drug Delivery Coating Sales Growth
5 Americas
5.1 Americas Degradable Drug Delivery Coating Sales by Country
5.1.1 Americas Degradable Drug Delivery Coating Sales by Country (2018-2023)
5.1.2 Americas Degradable Drug Delivery Coating Revenue by Country (2018-2023)
5.2 Americas Degradable Drug Delivery Coating Sales by Type
5.3 Americas Degradable Drug Delivery Coating Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Degradable Drug Delivery Coating Sales by Region
6.1.1 APAC Degradable Drug Delivery Coating Sales by Region (2018-2023)
6.1.2 APAC Degradable Drug Delivery Coating Revenue by Region (2018-2023)
6.2 APAC Degradable Drug Delivery Coating Sales by Type
6.3 APAC Degradable Drug Delivery Coating Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Degradable Drug Delivery Coating by Country
7.1.1 Europe Degradable Drug Delivery Coating Sales by Country (2018-2023)
7.1.2 Europe Degradable Drug Delivery Coating Revenue by Country (2018-2023)
7.2 Europe Degradable Drug Delivery Coating Sales by Type
7.3 Europe Degradable Drug Delivery Coating Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Degradable Drug Delivery Coating by Country
8.1.1 Middle East & Africa Degradable Drug Delivery Coating Sales by Country (2018-2023)
8.1.2 Middle East & Africa Degradable Drug Delivery Coating Revenue by Country (2018-2023)
8.2 Middle East & Africa Degradable Drug Delivery Coating Sales by Type
8.3 Middle East & Africa Degradable Drug Delivery Coating Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Degradable Drug Delivery Coating
10.3 Manufacturing Process Analysis of Degradable Drug Delivery Coating
10.4 Industry Chain Structure of Degradable Drug Delivery Coating
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Degradable Drug Delivery Coating Distributors
11.3 Degradable Drug Delivery Coating Customer
12 World Forecast Review for Degradable Drug Delivery Coating by Geographic Region
12.1 Global Degradable Drug Delivery Coating Market Size Forecast by Region
12.1.1 Global Degradable Drug Delivery Coating Forecast by Region (2024-2029)
12.1.2 Global Degradable Drug Delivery Coating Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Degradable Drug Delivery Coating Forecast by Type
12.7 Global Degradable Drug Delivery Coating Forecast by Application
13 Key Players Analysis
13.1 Surmodics
13.1.1 Surmodics Company Information
13.1.2 Surmodics Degradable Drug Delivery Coating Product Portfolios and Specifications
13.1.3 Surmodics Degradable Drug Delivery Coating Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Surmodics Main Business Overview
13.1.5 Surmodics Latest Developments
13.2 Hydromer
13.2.1 Hydromer Company Information
13.2.2 Hydromer Degradable Drug Delivery Coating Product Portfolios and Specifications
13.2.3 Hydromer Degradable Drug Delivery Coating Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Hydromer Main Business Overview
13.2.5 Hydromer Latest Developments
13.3 DSM Biomedical
13.3.1 DSM Biomedical Company Information
13.3.2 DSM Biomedical Degradable Drug Delivery Coating Product Portfolios and Specifications
13.3.3 DSM Biomedical Degradable Drug Delivery Coating Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 DSM Biomedical Main Business Overview
13.3.5 DSM Biomedical Latest Developments
13.4 Harland Medical Systems
13.4.1 Harland Medical Systems Company Information
13.4.2 Harland Medical Systems Degradable Drug Delivery Coating Product Portfolios and Specifications
13.4.3 Harland Medical Systems Degradable Drug Delivery Coating Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Harland Medical Systems Main Business Overview
13.4.5 Harland Medical Systems Latest Developments
13.5 Biocoat
13.5.1 Biocoat Company Information
13.5.2 Biocoat Degradable Drug Delivery Coating Product Portfolios and Specifications
13.5.3 Biocoat Degradable Drug Delivery Coating Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Biocoat Main Business Overview
13.5.5 Biocoat Latest Developments
13.6 Coatings2Go
13.6.1 Coatings2Go Company Information
13.6.2 Coatings2Go Degradable Drug Delivery Coating Product Portfolios and Specifications
13.6.3 Coatings2Go Degradable Drug Delivery Coating Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Coatings2Go Main Business Overview
13.6.5 Coatings2Go Latest Developments
13.7 AST Products
13.7.1 AST Products Company Information
13.7.2 AST Products Degradable Drug Delivery Coating Product Portfolios and Specifications
13.7.3 AST Products Degradable Drug Delivery Coating Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 AST Products Main Business Overview
13.7.5 AST Products Latest Developments
13.8 Surface Solutions Group
13.8.1 Surface Solutions Group Company Information
13.8.2 Surface Solutions Group Degradable Drug Delivery Coating Product Portfolios and Specifications
13.8.3 Surface Solutions Group Degradable Drug Delivery Coating Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Surface Solutions Group Main Business Overview
13.8.5 Surface Solutions Group Latest Developments
13.9 ISurTec
13.9.1 ISurTec Company Information
13.9.2 ISurTec Degradable Drug Delivery Coating Product Portfolios and Specifications
13.9.3 ISurTec Degradable Drug Delivery Coating Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ISurTec Main Business Overview
13.9.5 ISurTec Latest Developments
13.10 AdvanSource Biomaterials
13.10.1 AdvanSource Biomaterials Company Information
13.10.2 AdvanSource Biomaterials Degradable Drug Delivery Coating Product Portfolios and Specifications
13.10.3 AdvanSource Biomaterials Degradable Drug Delivery Coating Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 AdvanSource Biomaterials Main Business Overview
13.10.5 AdvanSource Biomaterials Latest Developments
13.11 Teleflex
13.11.1 Teleflex Company Information
13.11.2 Teleflex Degradable Drug Delivery Coating Product Portfolios and Specifications
13.11.3 Teleflex Degradable Drug Delivery Coating Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Teleflex Main Business Overview
13.11.5 Teleflex Latest Developments
13.12 Argon Medical
13.12.1 Argon Medical Company Information
13.12.2 Argon Medical Degradable Drug Delivery Coating Product Portfolios and Specifications
13.12.3 Argon Medical Degradable Drug Delivery Coating Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Argon Medical Main Business Overview
13.12.5 Argon Medical Latest Developments
14 Research Findings and Conclusion